Gevo (GEVO) Downgraded by Zacks Investment Research to “Hold”

Zacks Investment Research lowered shares of Gevo (NASDAQ:GEVO) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

Other equities research analysts have also issued reports about the stock. HC Wainwright reaffirmed a buy rating and issued a $12.00 price objective on shares of Gevo in a research note on Tuesday, November 7th. ValuEngine lowered shares of Gevo from a sell rating to a strong sell rating in a research note on Thursday, November 9th.

Gevo (NASDAQ:GEVO) traded up $0.09 on Wednesday, reaching $0.70. 4,493,100 shares of the company’s stock were exchanged, compared to its average volume of 1,742,733. Gevo has a 52-week low of $0.53 and a 52-week high of $5.35. The company has a quick ratio of 1.23, a current ratio of 1.54 and a debt-to-equity ratio of 0.21. The company has a market cap of $13.83, a price-to-earnings ratio of -0.40 and a beta of 3.09.

Gevo (NASDAQ:GEVO) last posted its earnings results on Monday, November 6th. The energy company reported ($0.36) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.05. Gevo had a negative net margin of 84.42% and a negative return on equity of 40.58%. The firm had revenue of $7.70 million for the quarter, compared to analyst estimates of $5.49 million. research analysts expect that Gevo will post -1.69 EPS for the current fiscal year.

A hedge fund recently raised its stake in Gevo stock. Virtu KCG Holdings LLC grew its position in Gevo, Inc. (NASDAQ:GEVO) by 557.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 182,390 shares of the energy company’s stock after purchasing an additional 154,654 shares during the quarter. Virtu KCG Holdings LLC owned approximately 1.21% of Gevo worth $126,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 7.07% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2018/01/05/gevo-gevo-downgraded-by-zacks-investment-research-to-hold.html.

About Gevo

Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.

Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply